Accelerating drug discovery with market leading cell line generation
Sygnature Discovery appoints Chair
Pathios and Sygnature partner against faulty membrane protein
Sygnature Discovery makes two key appointments as expansion continues
Sygnature Discovery and RenaSci link up in metabolic and CNS disorders
Sygnature Discovery’s group invests in new start up, Peak Proteins
Sygnature Discovery makes three key appointments
Wellcome Trust grants BerGenBio Seeding Drug Discovery Award of £1.6m
Sygnature Discovery hires Director of Business Development
Bayer HealthCare to coordinate European Lead Factory
Sygnature Discovery appoints VP of Business Development – North America
Sygnature Discovery and Pneumolabs to collaborate
Sygnature celebrates official opening of new research labs
Sygnature Chemical Services becomes Sygnature Discovery
